Five and Ten Year Results of the CMK21 Hip System
Trial Snapshot
- Phase
- Not Applicable
- Status
- Terminated
- Sponsor
- Smith & Nephew, Inc.
- Enrollment
- 100
- Locations
- 2
- Primary Endpoint
- Implant revision rate
Study Overview
Brief Summary
Five and ten year results of the CMK21 Hip system
Detailed Description
This study is being conducted to collect long term retrospective and prospective clinical and radiological data to evaluate the safety of revision rate and adverse events, and efficacy of clinical and patient assessment of the CMK21 hip stem in primary total hip arthroplasty.
Study Design
- Study Type
- Observational
- Observational Model
- Other
- Time Perspective
- Cross Sectional
Eligibility Criteria
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Implant revision rate
Time Frame: 10 years
Listing of implants status at 10 years to analyse the survival rate
Device related adverse events
Time Frame: 5 and 10 years
Device related adverse events will be collected to monitor the safety
Radiographic assessment
Time Frame: 5 and 10 Years
the occurrence of cement tears/fractures
Secondary Outcomes
- Harris Hip Score (HHS)(5 and 10 years)
- EuroQoL Five Dimensions Questionnaire (EQ-5D)(5 and 10 years)
